Continuing the BMO Healthcare Hidden Gems series, we hosted a call with Outset Medical (private), an emerging medical technology company set to disrupt the treatment of kidney failure with its Tablo device. Tablo is a “simple, flexible and untethered “ solution to shift the treatment paradigm for dialysis patients, creating a true consumer experience by utilizing digital health tools and reducing labor and infrastructure costs.
Outset Medical is positioned to transform the $80-90 billion dialysis market (including $34 billion spent by Medicare each year, or 7% of the Medicare budget) by introducing a new on-demand and self-care treatment platform called Tablo for both acute (ICU) and chronic (in-center) dialysis treatment. The device’s key pillars include: 1) consumer design; 2) infrastructure free dialysis; and 3) wireless data transmission.
Read More: https://bmo.bluematrix.com/docs/shorthtml/1c451604-e151-4ab0-9655-e5d438882a00.html
Via: BMO Capital Markets
Via: WQAD 8
PHILADELPHIA – Each year, more than 300,000 people in the U.S. are diagnosed with carotid artery disease.
Office of the President Established to Lead Company during Medical Leave
Phase 1a Study Will Assess Novel Immuno-Oncology Therapeutic Candidate as a Single Agent in Solid Tumors
Via: WKOW 27
MADISON (WKOW) -- A new procedure at a Madison hospital is aiming to reduce the risks for people with cardiovascular problems.
CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a neuromodulation company, announced today the appointment of Tom Wilder as President and CEO.
Hinge Health, a fledgling digital health startup that’s building hardware and software to tackle musculoskeletal (MSK) disorders, has raised $8 million in a Series A round of funding led by European VC giant Atomico, with participation from existing seed investors, including Eleven Two Capital and the Vertical Group.
Silk Road Medical said today it raised $47 million in a new funding round to support its Enroute products designed for transcarotid artery revascularization procedures.
Technology is offering a new fix for one of the most confounding health-care challenges: getting patients with chronic disease to take better care of themselves.